{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:23:29Z","timestamp":1788290609802,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s10792-018-0857-7","type":"journal-article","created":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T12:01:43Z","timestamp":1518436903000},"page":"611-621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Retinal single-layer analysis with optical coherence tomography shows inner retinal layer thinning in Huntington\u2019s disease as a potential biomarker"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1413-2528","authenticated-orcid":false,"given":"Duygu","family":"Gulmez Sevim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metin","family":"Unlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Gultekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagatay","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,12]]},"reference":[{"issue":"9","key":"857_CR1","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1002\/mds.25075","volume":"27","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N (2012) The incidence and prevalence of Huntington\u2019s disease: a systematic review and meta-analysis. Mov Disord 27(9):1083\u20131091. \n                    https:\/\/doi.org\/10.1002\/mds.25075","journal-title":"Mov Disord"},{"issue":"6","key":"857_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 72(6):971\u2013983","journal-title":"Cell"},{"issue":"11","key":"857_CR3","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1007\/s00415-015-7869-2","volume":"262","author":"HM Kersten","year":"2015","unstructured":"Kersten HM, Danesh-Meyer HV, Kilfoyle DH, Roxburgh RH (2015) Optical coherence tomography findings in Huntington\u2019s disease: a potential biomarker of disease progression. J Neurol 262(11):2457\u20132465. \n                    https:\/\/doi.org\/10.1007\/s00415-015-7869-2","journal-title":"J Neurol"},{"issue":"3","key":"857_CR4","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/mds.26486","volume":"31","author":"C Andrade","year":"2016","unstructured":"Andrade C, Beato J, Monteiro A, Costa A, Penas S, Guimaraes J, Reis FF, Garrett C (2016) Spectral-domain optical coherence tomography as a potential biomarker in Huntington\u2019s disease. Mov Disord 31(3):377\u2013383. \n                    https:\/\/doi.org\/10.1002\/mds.26486","journal-title":"Mov Disord"},{"issue":"5","key":"857_CR5","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00401-005-1092-7","volume":"110","author":"E Petrasch-Parwez","year":"2005","unstructured":"Petrasch-Parwez E, Saft C, Schlichting A, Andrich J, Napirei M, Arning L, Wieczorek S, Dermietzel R, Epplen JT (2005) Is the retina affected in Huntington disease? Acta Neuropathol 110(5):523\u2013525. \n                    https:\/\/doi.org\/10.1007\/s00401-005-1092-7","journal-title":"Acta Neuropathol"},{"key":"857_CR6","doi-asserted-by":"publisher","first-page":"728457","DOI":"10.1155\/2012\/728457","volume":"2012","author":"EM Shrier","year":"2012","unstructured":"Shrier EM, Adam CR, Spund B, Glazman S, Bodis-Wollner I (2012) Interocular asymmetry of foveal thickness in Parkinson disease. J Ophthalmol 2012:728457. \n                    https:\/\/doi.org\/10.1155\/2012\/728457","journal-title":"J Ophthalmol"},{"issue":"5","key":"857_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/ana.410410521","volume":"41","author":"JB Penney Jr","year":"1997","unstructured":"Penney JB Jr, Vonsattel JP, MacDonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington\u2019s disease. Ann Neurol 41(5):689\u2013692. \n                    https:\/\/doi.org\/10.1002\/ana.410410521","journal-title":"Ann Neurol"},{"issue":"2","key":"857_CR8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group","year":"1996","unstructured":"Huntington Study Group (1996) Unified Huntington\u2019s Disease Rating Scale: reliability and consistency. Mov Disord 11(2):136\u2013142. \n                    https:\/\/doi.org\/10.1002\/mds.870110204","journal-title":"Mov Disord"},{"key":"857_CR9","doi-asserted-by":"publisher","first-page":"128517","DOI":"10.1155\/2014\/128517","volume":"2014","author":"JJ Gonzalez-Lopez","year":"2014","unstructured":"Gonzalez-Lopez JJ, Rebolleda G, Leal M, Oblanca N, Munoz-Negrete FJ, Costa-Frossard L, Alvarez-Cermeno JC (2014) Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosis. Biomed Res Int 2014:128517. \n                    https:\/\/doi.org\/10.1155\/2014\/128517","journal-title":"Biomed Res Int"},{"issue":"6","key":"857_CR10","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1167\/iovs.04-0335","volume":"46","author":"H Ishikawa","year":"2005","unstructured":"Ishikawa H, Stein DM, Wollstein G, Beaton S, Fujimoto JG, Schuman JS (2005) Macular segmentation with optical coherence tomography. Invest Ophthalmol Vis Sci 46(6):2012\u20132017. \n                    https:\/\/doi.org\/10.1167\/iovs.04-0335","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"857_CR11","doi-asserted-by":"publisher","first-page":"148394","DOI":"10.1155\/2011\/148394","volume":"2011","author":"F Costello","year":"2011","unstructured":"Costello F (2011) Evaluating the use of optical coherence tomography in optic neuritis. Mult Scler Int 2011:148394. \n                    https:\/\/doi.org\/10.1155\/2011\/148394","journal-title":"Mult Scler Int"},{"issue":"3","key":"857_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s11910-012-0260-0","volume":"12","author":"KS Sitarz","year":"2012","unstructured":"Sitarz KS, Chinnery PF, Yu-Wai-Man P (2012) Disorders of the optic nerve in mitochondrial cytopathies: new ideas on pathogenesis and therapeutic targets. Curr Neurol Neurosci Rep 12(3):308\u2013317. \n                    https:\/\/doi.org\/10.1007\/s11910-012-0260-0","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"10","key":"857_CR13","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1177\/1352458514523498","volume":"20","author":"D Narayanan","year":"2014","unstructured":"Narayanan D, Cheng H, Bonem KN, Saenz R, Tang RA, Frishman LJ (2014) Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis. Mult Scler 20(10):1331\u20131341. \n                    https:\/\/doi.org\/10.1177\/1352458514523498","journal-title":"Mult Scler"},{"issue":"2","key":"857_CR14","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ophtha.2013.09.035","volume":"121","author":"E Garcia-Martin","year":"2014","unstructured":"Garcia-Martin E, Polo V, Larrosa JM, Marques ML, Herrero R, Martin J, Ara JR, Fernandez J, Pablo LE (2014) Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coherence tomography. Ophthalmology 121(2):573\u2013579. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2013.09.035","journal-title":"Ophthalmology"},{"key":"857_CR15","doi-asserted-by":"publisher","first-page":"8503859","DOI":"10.1155\/2016\/8503859","volume":"2016","author":"M Satue","year":"2016","unstructured":"Satue M, Obis J, Rodrigo MJ, Otin S, Fuertes MI, Vilades E, Gracia H, Ara JR, Alarcia R, Polo V, Larrosa JM, Pablo LE, Garcia-Martin E (2016) Optical coherence tomography as a biomarker for diagnosis, progression, and prognosis of neurodegenerative diseases. J Ophthalmol 2016:8503859. \n                    https:\/\/doi.org\/10.1155\/2016\/8503859","journal-title":"J Ophthalmol"},{"issue":"2","key":"857_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/archopht.118.2.235","volume":"118","author":"TM Nork","year":"2000","unstructured":"Nork TM, Ver Hoeve JN, Poulsen GL, Nickells RW, Davis MD, Weber AJ, Vaegan Sarks SH, Lemley HL, Millecchia LL (2000) Swelling and loss of photoreceptors in chronic human and experimental glaucomas. Arch Ophthalmol 118(2):235\u2013245","journal-title":"Arch Ophthalmol"},{"key":"857_CR17","doi-asserted-by":"publisher","first-page":"264803","DOI":"10.1155\/2011\/264803","volume":"2011","author":"N Fan","year":"2011","unstructured":"Fan N, Huang N, Lam DS, Leung CK (2011) Measurement of photoreceptor layer in glaucoma: a spectral-domain optical coherence tomography study. J Ophthalmol 2011:264803. \n                    https:\/\/doi.org\/10.1155\/2011\/264803","journal-title":"J Ophthalmol"},{"issue":"4","key":"857_CR18","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ana.410340411","volume":"34","author":"W Paulus","year":"1993","unstructured":"Paulus W, Schwarz G, Werner A, Lange H, Bayer A, Hofschuster M, Muller N, Zrenner E (1993) Impairment of retinal increment thresholds in Huntington\u2019s disease. Ann Neurol 34(4):574\u2013578. \n                    https:\/\/doi.org\/10.1002\/ana.410340411","journal-title":"Ann Neurol"},{"issue":"2","key":"857_CR19","doi-asserted-by":"publisher","first-page":"e56026","DOI":"10.1371\/journal.pone.0056026","volume":"8","author":"M Li","year":"2013","unstructured":"Li M, Yasumura D, Ma AA, Matthes MT, Yang H, Nielson G, Huang Y, Szoka FC, Lavail MM, Diamond MI (2013) Intravitreal administration of HA-1077, a ROCK inhibitor, improves retinal function in a mouse model of huntington disease. PLoS ONE 8(2):e56026. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0056026","journal-title":"PLoS ONE"},{"issue":"3","key":"857_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.nbd.2011.12.004","volume":"45","author":"AH Batcha","year":"2012","unstructured":"Batcha AH, Greferath U, Jobling AI, Vessey KA, Ward MM, Nithianantharajah J, Hannan AJ, Kalloniatis M, Fletcher EL (2012) Retinal dysfunction, photoreceptor protein dysregulation and neuronal remodelling in the R6\/1 mouse model of Huntington\u2019s disease. Neurobiol Dis 45(3):887\u2013896. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2011.12.004","journal-title":"Neurobiol Dis"},{"issue":"26","key":"857_CR21","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/hmg\/11.26.3351","volume":"11","author":"D Helmlinger","year":"2002","unstructured":"Helmlinger D, Yvert G, Picaud S, Merienne K, Sahel J, Mandel JL, Devys D (2002) Progressive retinal degeneration and dysfunction in R6 Huntington\u2019s disease mice. Hum Mol Genet 11(26):3351\u20133359","journal-title":"Hum Mol Genet"},{"issue":"13","key":"857_CR22","first-page":"1644-1644","volume":"55","author":"MA Johnson","year":"2014","unstructured":"Johnson MA, Gelderblom H, R\u00fcther K, Priller J, Bernstein SL (2014) Evidence that Huntington\u2019s Disease Affects Retinal Structure and Function. Invest Ophthalmol Vis Sci 55(13):1644-1644","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-018-0857-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0857-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0857-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T06:58:46Z","timestamp":1567234726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-018-0857-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,12]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1007\/s10792-018-0857-7","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,12]]},"assertion":[{"value":"16 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}